AstraZeneca buys Chinese CAR-T biotech Gracell in a $1.2bn deal
Pharmaceutical Technology
DECEMBER 27, 2023
The deal is worth approximately $1.2bn in combined upfront and potential contingent value payments and is expected to close in Q1 2024.
Wed.Dec 27, 2023
246 
Amgen's request for full approval of Lumakras in lung cancer denied by FDA
Fierce Pharma
DECEMBER 27, 2023
Amgen’s request to gain full approval of Lumakras in non-small cell lung cancer has been rejected by the FDA. | Amgen’s request to gain full approval of Lumakras in non-small cell lung cancer has been rejected by the FDA. The California biopharma will now have to conduct an additional confirmatory trial to gain the coveted FDA nod.
Join 21,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bristol Myers Squibb agrees to acquire RPT company RayzeBio for $4.1bn
Pharmaceutical Technology
DECEMBER 27, 2023
Bristol Myers Squibb (BMS) has signed a definitive agreement for the acquisition of RayzeBio in a total equity value of nearly $4.1bn.
BMS strikes again, with $4.1bn RayzeBio takeover bid
pharmaphorum
DECEMBER 27, 2023
Bristol-Myers Squibb makes a foray into the radiopharmaceutical category with a $4.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
ARTBIO divulges plans for proprietary isotope manufacturing technology
Pharmaceutical Technology
DECEMBER 27, 2023
ARTBIO is developing a proprietary radiotherapy manufacturing technology to overcome distribution and supply chain challenges.
Pfizer's Hospira recall spree bleeds into 2024 with product pulls for multiple hospital drugs in shortage
Fierce Pharma
DECEMBER 27, 2023
After a year plagued by recalls, Pfizer’s sterile injectables unit Hospira seems no closer to righting the ship over its glass-contamination woes. | After a year plagued by recalls, Pfizer’s sterile injectables unit Hospira seems no closer to righting the ship over its glass-contamination woes. Shortly before the holiday, Hospira announced two separate recalls over the potential presence of glass particulates in vials and syringes of certain hospital meds.
Sign up to get articles personalized to your interests!
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
More Trending
Hospital Price Transparency Gets a Boost by PatientRightsAdvocate.org
XTalks
DECEMBER 27, 2023
PatientRightsAdvocate.org (PRA), a leading non-profit organization championing the cause of healthcare price transparency in America, launched Hospital Price Files Finder , a freely available dashboard tool containing pricing files for 6,000 hospitals nationwide. It is a searchable tool containing all available hospital pricing files in spreadsheets that are human and machine-readable, converted from the original format as necessary.
Looking to the future of UK medical device exports
pharmaphorum
DECEMBER 27, 2023
In this second of our festive podcast series, the pharmaphorum podcast welcomed Brandon Medical CEO Keith Jackson and the Association of British HealthTech Industries (or ABHI) director of communications, Jonathan Evans, to discuss UK medical device exports, including a particular recent strategic APAC partnership and the general and ongoing representation of industry innovation to stakeholders including government, NHS, and regulators.
New patent for IMPAX drug TWINJECT 0.15
Drug Patent Watch
DECEMBER 27, 2023
Annual Drug Patent Expirations for TWINJECT+0.15 Twinject 0.15 is a drug marketed by Impax and is included in one NDA. It is available from four suppliers. There are two patents… The post New patent for IMPAX drug TWINJECT 0.15 appeared first on DrugPatentWatch - Make Better Decisions.
Update: Apple Watches back on sale after appeal
pharmaphorum
DECEMBER 27, 2023
Apple will appeal a decision by the USTR not to veto a ban on US imports of some of its smartwatches, found to violate patents held by wearables company Masimo
New patent for IMPAX drug TWINJECT 0.3
Drug Patent Watch
DECEMBER 27, 2023
Annual Drug Patent Expirations for TWINJECT+0.3 Twinject 0.3 is a drug marketed by Impax and is included in one NDA. It is available from four suppliers. There are two patents… The post New patent for IMPAX drug TWINJECT 0.3 appeared first on DrugPatentWatch - Make Better Decisions.
The rapidly evolving role of patient organisations
pharmaphorum
DECEMBER 27, 2023
Patient organisations play a crucial role in the rapidly evolving landscape of healthcare, life sciences, and research. Learn about their role in advocacy, research, and navigating regulatory processes in this informative article.
New patent for IMPAX drug ADRENACLICK
Drug Patent Watch
DECEMBER 27, 2023
Annual Drug Patent Expirations for ADRENACLICK Adrenaclick is a drug marketed by Impax and is included in one NDA. It is available from four suppliers. There are two patents protecting… The post New patent for IMPAX drug ADRENACLICK appeared first on DrugPatentWatch - Make Better Decisions.
6 Top Picks: Clinical Trial Blogs Not to Miss
Imperical Blog
DECEMBER 27, 2023
The Imperial blog team took a look at our 2023 clinical trial blogs, and we’re shining the spotlight on our top six picks. So here they are, in no particular order: six clinical trial blogs worth reading (and re-reading). 1. Supply Chain: Master these key… The post 6 Top Picks: Clinical Trial Blogs Not to Miss appeared first on Imperial Clinical Research Services Blog.
The New Age of Decentralized Clinical Trials
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Velocity Supported Clinical Trials That Led to 12 Product Approvals in 2023
Velocity Clinical Research
DECEMBER 27, 2023
Velocity has made an incredible impact over the past year! Our sites conducted clinical trials that supported 12 U.S. product approvals in 2023, contributing to the betterment of global health. To date, Velocity has contributed to research programs for over 50 product approvals. From pioneering vaccines to cutting-edge drugs, Velocity’s team worldwide has worked diligently to support these significant achievements.
Top 3 Most-Read Supply Chain Logistics Pieces of the Year
Pharmaceutical Commerce
DECEMBER 27, 2023
The most popular pieces pertaining to the supply chain featured ADMs, vaccine supply chains, and wholesalers.
Which pharmaceutical companies have the most drug patents in Czech Republic?
Drug Patent Watch
DECEMBER 27, 2023
This chart shows the pharmaceutical companies with the most patents in Czech Republic. Patents must be filed in each country (or, in some cases regional patent office) where patent protection… The post Which pharmaceutical companies have the most drug patents in Czech Republic? appeared first on DrugPatentWatch - Make Better Decisions.
A Look Ahead: Site Trends for 2024
WCG Clinical
DECEMBER 27, 2023
This content is password protected. To view it please enter your password below: Password: The post A Look Ahead: Site Trends for 2024 appeared first on WCG.
Apple to appeal after US backs ban on watch imports
pharmaphorum
DECEMBER 27, 2023
Apple has launched an appeal against a decision by the Biden administration not to veto a ban on imports into the US of some of its smartwatches, after a complaint that the devices violate patents held by Masimo on the use of wearables to measure blood oxygen levels.
Site Readiness in Vaccine Trials: Lessons Learned from the COVID-19 Pandemic
WCG Clinical
DECEMBER 27, 2023
This content is password protected. To view it please enter your password below: Password: The post Site Readiness in Vaccine Trials: Lessons Learned from the COVID-19 Pandemic appeared first on WCG.
2024: Recapturing the Progress Made with CTA Negotiations During the Pandemic
WCG Clinical
DECEMBER 27, 2023
This content is password protected. To view it please enter your password below: Password: The post 2024: Recapturing the Progress Made with CTA Negotiations During the Pandemic appeared first on WCG.
Patient Recruitment Barriers in Oncology
WCG Clinical
DECEMBER 27, 2023
This content is password protected. To view it please enter your password below: Password: The post Patient Recruitment Barriers in Oncology appeared first on WCG.
The New Age of Decentralized Clinical Trials
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
2024: Past Promises, the Future Hope of Neuroscience Clinical Research
WCG Clinical
DECEMBER 27, 2023
This content is password protected. To view it please enter your password below: Password: The post 2024: Past Promises, the Future Hope of Neuroscience Clinical Research appeared first on WCG.
Psychedelics: From Powerful Potential to the Psychiatrist’s Practice
WCG Clinical
DECEMBER 27, 2023
This content is password protected. To view it please enter your password below: Password: The post Psychedelics: From Powerful Potential to the Psychiatrist’s Practice appeared first on WCG.
The Impact of Artificial Intelligence (AI) on Ethical Review by IRBs
WCG Clinical
DECEMBER 27, 2023
This content is password protected. To view it please enter your password below: Password: The post The Impact of Artificial Intelligence (AI) on Ethical Review by IRBs appeared first on WCG.
Deploying AI Across the Clinical Trial Life Cycle?
WCG Clinical
DECEMBER 27, 2023
This content is password protected. To view it please enter your password below: Password: The post Deploying AI Across the Clinical Trial Life Cycle appeared first on WCG.
Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Diversity, Equity, and Inclusion in Rare Disease Clinical Trials: Current Opportunities and Outcomes
WCG Clinical
DECEMBER 27, 2023
This content is password protected. To view it please enter your password below: Password: The post Diversity, Equity, and Inclusion in Rare Disease Clinical Trials: Current Opportunities and Outcomes appeared first on WCG.
The Decentralization of Vaccines in 2024 and Beyond
WCG Clinical
DECEMBER 27, 2023
This content is password protected. To view it please enter your password below: Password: The post The Decentralization of Vaccines in 2024 and Beyond appeared first on WCG.
Let's personalize your content